Evidence map›Paper›PMID 31846472›Full record

ArticlePLoS genetics2019

A transcriptome-based signature of pathological angiogenesis predicts breast cancer patient survival.

Rodrigo Guarischi-Sousa, Jhonatas S Monteiro, Lilian C Alecrim, Jussara S Michaloski, Laura B Cardeal, Elisa N Ferreira, Dirce M Carraro, Diana N Nunes, Emmanuel Dias-Neto, Jüri Reimand and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Obesity and leptin in breast cancer angiogenesis.Frontiers in endocrinology · 2024
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Rodrigo Guarischi-SousaBiochemistry Department, Institute of Chemistry, University of São Paulo, São Paulo, Brazil.ORCID 0000-0002-3614-9996
Jhonatas S MonteiroBiochemistry Department, Institute of Chemistry, University of São Paulo, São Paulo, Brazil.ORCID 0000-0003-4985-4608
Lilian C AlecrimBiochemistry Department, Institute of Chemistry, University of São Paulo, São Paulo, Brazil.ORCID 0000-0002-7566-4595
Jussara S MichaloskiBiochemistry Department, Institute of Chemistry, University of São Paulo, São Paulo, Brazil.ORCID 0000-0002-8029-199X
Laura B CardealBiochemistry Department, Institute of Chemistry, University of São Paulo, São Paulo, Brazil.
Elisa N FerreiraInternational Research Center (CIPE) A.C. Camargo Cancer Center, São Paulo, SP, Brazil.
Dirce M CarraroInternational Research Center (CIPE) A.C. Camargo Cancer Center, São Paulo, SP, Brazil.
Diana N NunesInternational Research Center (CIPE) A.C. Camargo Cancer Center, São Paulo, SP, Brazil.ORCID 0000-0003-0751-4701
Emmanuel Dias-NetoInternational Research Center (CIPE) A.C. Camargo Cancer Center, São Paulo, SP, Brazil.ORCID 0000-0001-5670-8559
Jüri ReimandComputational Biology Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Paul C BoutrosDepartment of Human Genetics, University of California Los Angeles (UCLA), Los Angeles, CA, United States of America.ORCID 0000-0003-0553-7520
João C SetubalBiochemistry Department, Institute of Chemistry, University of São Paulo, São Paulo, Brazil.ORCID 0000-0001-9174-2816
Ricardo J GiordanoBiochemistry Department, Institute of Chemistry, University of São Paulo, São Paulo, Brazil.ORCID 0000-0001-8116-6771
Universidade de São Paulo · BRAC Camargo Hospital · BROntario Institute for Cancer Research · CAUniversity of California, Los Angeles · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The specific genes and molecules that drive physiological angiogenesis differ from those involved in pathological angiogenesis, suggesting distinct mechanisms for these seemingly related processes. Unveiling genes and pathways preferentially associated with pathologic angiogenesis is key to understanding its mechanisms, thereby facilitating development of novel approaches to managing angiogenesis-dependent diseases. To better understand these different processes, we elucidated the transcriptome of the mouse retina in the well-accepted oxygen-induced retinopathy (OIR) model of pathological angiogenesis. We identified 153 genes changed between normal and OIR retinas, which represent a molecular signature relevant to other angiogenesis-dependent processes such as cancer. These genes robustly predict the survival of breast cancer patients, which was validated in an independent 1,000-patient test cohort (40% difference in 15-year survival; p = 2.56 x 10-21). These results suggest that the OIR model reveals key genes involved in pathological angiogenesis, and these may find important applications in stratifying tumors for treatment intensification or for angiogenesis-targeted therapies.

Indexed as

AgedAnimalsBreast NeoplasmsDisease Models, AnimalFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticGene Regulatory NetworksHigh-Throughput Nucleotide SequencingHumansMiceMiddle AgedNeovascularization, PathologicOxygenRetinaSequence Analysis, RNAOxygen

Identifiers

PMID31846472
PMCPMC6917213
OpenAlexW2994641713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.